HopeStage
Back to all studies
CompletedNCT00961454

Light-based treatment and brain blood flow in depression

About this titleRead the official source — NCT00961454
Device studyAges 18–60United States
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.

Listed locations
BostonSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJanuary 2009
Recruitment status
Completed
Enrollment listed in the registry
10
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT00961454
Official title
Show the full official title

A Pilot Study to Evaluate the Ability of Photobiomodulation to Alter Cerebral Blood Flow in the Frontal Poles and to Affect the Emotional Status of Patients With Major Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Boston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies